From a clinical, morphological and molecular perspective, prostate cancer is a
heterogeneous disease. Primary prostate cancers are often multifocal, having …

Background Multiparametric magnetic resonance imaging (MRI), with or without MRI‐
targeted biopsy, is an alternative test to systematic transrectal ultrasonography‐guided …

The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …

One of the fundamental challenges in supervised learning for multimodal image registration
is the lack of ground-truth for voxel-level spatial correspondence. This work describes a …

Context Magnetic resonance imaging (MRI), with or without MRI-targeted biopsy (MRI
pathway), is an alternative test to systematic transrectal ultrasonography-guided biopsy in …

Currently, the findings of imaging procedures used for detection or staging of prostate
cancer depend on morphology of lymph nodes or bone metabolism and do not always meet …

Context The introduction of magnetic resonance imaging-guided biopsies (MRI-GB) has
changed the paradigm concerning prostate biopsies. Three techniques of MRI-GB are …

Background Guidelines advise multiparametric magnetic resonance imaging (mpMRI)
before repeat biopsy in patients with negative systematic biopsy (SB) and a suspicion of …

Background Multiparametric magnetic resonance imaging (mpMRI) undoubtedly affects the
diagnosis and treatment of localized prostate cancer (CaP). However, clinicians need a …

Context It remains unclear whether patients with a suspicion of prostate cancer (PCa) and
negative multiparametric magnetic resonance imaging (mpMRI) can safely obviate prostate …